Orgenesis Granted FDA Orphan Drug Designation for Autologous Insulin Producing Cells in the Treatment of Severe Hypoglycemia-Prone Diabetes Resulting from Total Pancreatectomy

Stock Information for Orgenesis Inc.

Loading

Please wait while we load your information from QuoteMedia.